HOME >> MEDICINE >> NEWS
Targeted toxins may revolutionize pain therapy

Imagine being able to zap chronic pain with a single injection. That is the hope of scientists working to develop toxins that kill only certain types of neurons. A leading candidate for pain treatment is substance P-saporin, a toxin that selectively kills neurons that carry pain signals from the spinal cord to the brain.

"We have a terrible time treating patients with chronic pain--it can be nearly impossible to provide relief without side effects that sacrifice quality of life," said Dr. Ronald G. Wiley, a professor of Neurology and Pharmacology at Vanderbilt University Medical Center.

Wiley and colleagues developed substance P-saporin by linking the plant toxin saporin to substance P, a peptide that normally participates in the transmission of painful stimuli. Substance P-saporin gains entry to neurons by binding to the substance P receptors that stud the surface. Once inside, saporin halts protein production and kills the cell.

In rats, the toxin blocks the development of extreme sensitivity to pain--hyperalgesia.

"We think that hyperalgesia is the basis of our worst clinical pain problems," Wiley said.

Substance P-saporin is just the beginning. Wiley has recently developed dermorphin-saporin--a similar toxin that is directed at the mu-opiate receptor, the site of action for morphine. He will use dermorphin-saporin to study how morphine works to relieve pain. It may also offer hope to chronic pain sufferers.

"In the next few years, these tools are definitely going to extend our understanding of the neurobiology of pain," Wiley said. "In addition, they offer novel, previously never available, therapeutic potential."

Wiley and others will participate in a Society for Neuroscience symposium entitled "Exciting new advances in pain research and treatment using receptor internalization technologies" on Thursday, October 28, in Room C124. A press conference to highlight the findings will be held in room C226 on Wednesday, October 27 at 9:0
'"/>

Contact: Matt Scanlan
matt.scanlan@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
27-Oct-1999


Page: 1 2

Related medicine news :

1. Targeted antiviral prophylaxis of flu case contacts could successfully contain pandemic influenza
2. Smallpox outbreak response: Targeted vaccination may be almost as effective as mass vaccination
3. Targeted smallpox vaccinations could be effective intervention against deliberate attack
4. Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia
5. Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV
6. Promising New Drug Uses Antibody Targeted Chemotherapy To Fight Leukemia
7. Targeted Protein Toxin Effective Against Persistent Brain Tumors
8. New breast cancer mannequin to revolutionize teaching of breast cancer awareness
9. SU scientist receives patent that could revolutionize medical magnetic resonance imaging
10. New discovery may revolutionize treatment for pain related to surgery, illness and injury
11. AmericasDoctor.com & Affiliated Research Centers announce merger that revolutionizes clinical trial recruitment, expedites pharmaceutical research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/7/2020)... ... July 07, 2020 , ... Mediaplanet recently launched an awareness initiative ... pandemic thrust this field into the spotlight and, as a result, the Bureau ... 2026. In partnership with South University — which offers a Master’s in ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... featured in Biocompare’s latest content hub— Future Lab: COVID-19 R&D . , ... advancements, trends, news, and products within specific scientific niches. Since their launch four ...
(Date:7/2/2020)... ... 02, 2020 , ... Dr. Christine Blaine has earned a stellar ... offices located in Staten Island, Huntington and NYC, NY. Her former Manhattan clinic, ... suite at The Parlor NYC at 160 Madison Avenue. Blaine Plastic Surgery ...
(Date:7/1/2020)... ... July 01, 2020 , ... Dexur’s analysis of Medicare ... Hospital , Porter Adventist Hospital , and Sky Ridge Medical Center ... Knee Replacement. Dexur’s value analysis tracks a patient’s episode of care from the date ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... it has been selected by Codiak BioSciences to support its cleanroom build out ... the cleanroom infrastructure for the drug substance and product manufacturing for its clinical ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... ... 2020 , ... COMPLIANCY GROUP in its continued efforts to ... associates create, receive, transmit, store, and maintain protected health information (PHI) on behalf ... HIPAA compliant, ensuring the confidentiality, integrity, and availability of PHI. , HIPAA ...
(Date:7/10/2020)... Calif. (PRWEB) , ... July ... ... Review , the leading review of business and technology for the pharmaceutical ... the development and manufacturing of the highest quality pharmaceutical products. QC ...
(Date:7/7/2020)... ... July 07, 2020 , ... With ... Navajo Nation residents, the 33 nonprofits who received the latest ISA Foundation ... round of funding, the foundation awarded grants totaling $838,527 to the U.S.-based 501(c)(3) ...
Breaking Medicine Technology:
Cached News: